- Filed
- Mar 31, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 27, 2025 | 60.59M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 54.13K sh |
| Capex | FY 2024 · Dec 31, 2023 | $53.43K |
| Operating Cash Flow | FY 2024 · Dec 31, 2023 | −$4.32M |
| Current Liabilities | FY 2024 · Dec 31, 2023 | $2.05M |
| Total Liabilities | FY 2024 · Dec 31, 2023 | $2.1M |
| Current Assets | FY 2024 · Dec 31, 2023 | $8.05M |
| Total Assets | FY 2024 · Dec 31, 2023 | $17.02M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$291.52 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$291.52 |
| Rd Expense | FY 2024 · Dec 31, 2023 | $982.68K |
| Net Income | FY 2024 · Dec 31, 2023 | −$14.55M |
| Operating Income | FY 2024 · Dec 31, 2023 | −$15.33M |
| Gross Profit | FY 2024 · Dec 31, 2023 | $6.66M |
| Revenue | FY 2024 · Dec 31, 2023 | $9.93M |
| Stockholders Equity | FY 2024 · Dec 31, 2022 | $20.98M |